$15.59 2.7%
CPRX Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for people with rare debilitating diseases, chronic neuromuscular and neurological diseases.

Catalyst Pharmaceuticals
Price $15.59
Target Price Sign up
Volume 7,170,000
Market Cap $1.79B
Year Range $12.01 - $17.29
Dividend Yield 0%
PE Ratio 27.11
Revenue per Employee $5,016,427
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2499M69M30M23M36M0.000
Q4 '23111M67M44M35M51M0.310
Q3 '23103M48M55M-31M-29M-0.290
Q2 '23100M40M59M38M55M0.530
Q1 '2385M46M39M30M42M0.260

Insider Transactions View All

Del Carmen Jeffrey filed to sell 18,427 shares at $16.1.
June 11 '24
INGENITO GARY filed to sell 51,391 shares at $16.2.
June 7 '24
Daly Richard J filed to sell 234,824 shares at $16.
June 5 '24
Tierney David S filed to sell 348,874 shares at $15.7.
April 10 '24

What is the Market Cap of Catalyst Pharmaceuticals?

The Market Cap of Catalyst Pharmaceuticals is $1.79B.

What is Catalyst Pharmaceuticals' PE Ratio?

As of today, Catalyst Pharmaceuticals' PE (Price to Earnings) ratio is 27.11.

How Many People Work at Catalyst Pharmaceuticals?

As of our latest update, Catalyst Pharmaceuticals employed approximately 82 people worldwide. However, it's important to note that Catalyst Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Catalyst Pharmaceuticals' revenue per employee?

$5,016,427. To calculate Catalyst Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Catalyst Pharmaceuticals?

Currently, the price of one share of Catalyst Pharmaceuticals stock is $15.59.

How can I analyze the CPRX stock price chart for investment decisions?

The CPRX stock price chart above provides a comprehensive visual representation of Catalyst Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Catalyst Pharmaceuticals shares. Our platform offers an up-to-date CPRX stock price chart, along with technical data analysis and alternative data insights.

Does CPRX offer dividends to its shareholders?

As of our latest update, Catalyst Pharmaceuticals (CPRX) does not offer dividends to its shareholders. Investors interested in Catalyst Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Catalyst Pharmaceuticals?

Some of the similar stocks of Catalyst Pharmaceuticals are Amgen, Gilead Sciences, Inovio Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.